Pharmacist-led telehealth deprescribing for people living with dementia and polypharmacy in primary care: A pilot study.
Ariel R GreenRosalphie QuilesAndrea E DaddatoJessica MerreyLinda WeffaldKathy GleasonQian-Li XueMeghan SwarthoutScott FeeserCynthia M BoydJennifer L WolffMarcela D BlinkaAnne M LibbyRebecca S BoxerPublished in: Journal of the American Geriatrics Society (2024)
Though complex, pharmacist-led telehealth deprescribing is feasible and may reduce medication burden in PLWD. To align with patient-care partner goals, pharmacists recommended deprescribing and prescribing. If scalable, such interventions may optimize goal-concordant care for PLWD.
Keyphrases
- primary care
- healthcare
- adverse drug
- general practice
- mild cognitive impairment
- palliative care
- physical activity
- quality improvement
- cognitive impairment
- pain management
- risk factors
- emergency department
- global health
- light emitting
- hiv testing
- hepatitis c virus
- health insurance
- men who have sex with men
- hiv infected
- human immunodeficiency virus